OLR1 and myocardial infarction: In the study by Nobuaki Kobayashi and colleagues, plasma levels of sLOX-1 were evaluated in 125 patients with STEMI, 44 with non-ST-segment elevation myocardial infarction (NSTEMI), and 125 without acute myocardial infarction (non-AMI).